Viz.ai, a leader in AI-driven disease detection and intelligent care coordination, has announced a partnership with the Addario Lung Cancer Medical Institute (ALCMI), a global network of 25 leading lung cancer research institutions.

This collaboration aims to enhance lung cancer outcomes through improved early detection, streamlined clinical workflows for nodule assessment, and optimized precision medicine.

The partnership seeks to combine ALCMI’s expertise in patient engagement and research with Viz.ai’s AI-powered care coordination network, which covers 1,700 hospitals and health systems. Key objectives of the initiative include:

• Utilizing AI to advance oncology research, early detection, clinical workflows, and patient protocols.
• Addressing healthcare disparities in rural and community settings by providing local physicians with advanced treatments and methodologies.

The collaboration represents a significant step toward improving lung cancer care and outcomes, with the goal of making substantial progress in early detection and treatment to enhance survival rates and overall patient care.





Source: viz.ai

Report Abuse